Discontinuation of first-line disease-modifying therapy in multiple sclerosisE. M. Coerver, A. Bourass, M. H. Wessels,Z. L. Van Kempen,B. Jasperse,F. Barkhof,J. Mostert,B. M. Uitdehaag,J. Killestein,E. M. StrijbisMULTIPLE SCLEROSIS JOURNAL（2022）引用 0|浏览19AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
